VivoSim
Pre-clinicalAt VivoSim we develop, human-relevant, customizable NAMkind™ 3-D liver and intestinal toxicology models that accelerate lead selection, de-risk compounds selection, and advance promising candidates with confidence.
Founded
2020
Focus
Small Molecules
About
At VivoSim we develop, human-relevant, customizable NAMkind™ 3-D liver and intestinal toxicology models that accelerate lead selection, de-risk compounds selection, and advance promising candidates with confidence.
Funding History
1Total raised: $2.5M
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile